Objective To explore the value of ultrasound intelligent diagnostic system combined with mammography for differentiating benign and malignant non-mass breast lesions(NMBL).Methods Totally 107 patients with NMBL were retrospectively enrolled,including 64 cases of malignant(malignant group)and 43 cases of benign lesions(benign group).Clinical,routine ultrasound,ultrasound intelligent diagnostic system(artificial intelligence[AI]system)and mammography data were compared between groups.Logistic regression analysis was performed,receiver operating characteristic(ROC)curves were drawn,the areas under the curves(AUC)were calculated,and the efficacy of AI system combined with mammography for differentiating benign and malignant NMBL was analyzed.Results Significant differences of the maximum diameter of lesion,ratio of axillary lymph node enlargement and suspected malignant calcification on mammography,as well as of AI system malignancy risk and AI system breast imaging reporting and data system(BI-RADS)classification were found between groups(all P＜0.05).AI system binary classification was obtained based on AI system malignancy risk.The AUC of suspected malignant calcification on mammography,AI system BI-RADS classification and AI system binary classification for differential diagnosis of benign and malignant NMBL was 0.840,0.810 and 0.817,respectively,while of suspected malignant calcification on mammography combined with AI system BI-RADS classification or AI system binary classification were both 0.856,higher than that of AI system BI-RADS classification/AI system binary classification alone(both P＜0.05)but not significantly different with that of suspected malignant calcification on mammography alone(both P＞0.05).Logistic regression analysis of age,the maximum diameter of lesion,axillary lymph node enlargement and suspected malignant calcification on mammography combined with AI system malignancy risk(model 1),AI system BI-RADS classification(model 2)or AI system binary classification(model 3)showed that suspected malignant calcification on mammography,AI system malignancy risk,AI system BI-RADS classification and AI system binary classification were all independent risk factors of malignant NMBL(all P＜0.05),and AUC of model 1,2 and 3 for differentiating benign and malignant NMBL was 0.966,0.964 and 0.957,respectively.Conclusion Ultrasound intelligent diagnostic system combined with mammography was helpful for differentiating benign and malignant NMBL.Combining with clinical indicators might improve diagnostic efficacy.

Objective To observe early changes of left atrial strain and left atrial stiffness index(LASI)in rabbits with left ventricular myocardial injury induced by adriamycin(ADM).Methods Eighteen New Zealand white rabbits were randomly divided into experimental group(n=12)and control group(n=6),while 2 mg/kg ADM was injected into rabbits in experimental group and 5 ml physiological saline was injected into rabbits in control group every week for a total of 4 weeks.Ultrasound examination was performed before injection of ADM/physiological saline,2 and 4 weeks after injection,respectively.Left atrial anteroposterior diameter(LAAPD),left ventricular end diastolic diameter(LVEDD),left ventricular ejection fraction(LVEF),lateral wall of mitral ring of early peak flow velocity(e),mitral valve orifice early peak flow velocity(E)/e,left ventricular global longitudinal strain(LVGLS),right ventricular collectivity long axis strain(RVCLS),left atrial strain during reservoir phase(LASr),left atrial strain during conduit phase(LAScd),left atrial strain during contraction phase(LASct)and LASI were obtained and analyzed.After ultrasound examination,myocardial changes were observed with pathological examination.Results Four weeks after injection,e in experimental group was significantly lower than that before injection,also lower than that 2 and 4 weeks after injection in control group(all P＜0.05).Significant differences of LASr,LAScd,LASct and LASI were found among different time points between groups(all P＜0.05).Two and 4 weeks after injection,the above 4 parameters in experimental group were all significantly different with those in control group(all P＜0.05).LASr,LASct and LASI were different among different time points,while LAScd before injection was higher than that 2 and 4 weeks after injection in experimental group(all P＜0.05).The pathological findings supported ultrasonic changes.Conclusion In early stage of ADM induced left ventricular myocardial injury in rabbits,changes of left atrial strain and LASI could be seen,which were more significant than those of LVGLS,RVCLS and LVEF,etc.

Portal hypertension(PH)is one of the most common complications of chronic liver disease,which can lead to gastroesophageal varices,spontaneous portosystemic shunt,ectopic varices and sinistral PH.The formation mechanisms,imaging characteristics,diagnosis and clinical management of collateral circulation in PH were reviewed in this article.

Objective To observe the value of body mass and body mass index(BMI)for calculating size specific dose estimate(SSDE)value of chest and abdominal CT in children.Methods Totally 486 children who underwent chest and abdominal CT scanning were retrospectively enrolled,including 201 underwent chest and 285 underwent abdominal CT scanning.SSDE value was calculated with software,body mass and BMI and recorded as SSDEstandard,SSDEweight and SSDEBMI,respectively,and the correlation and consistency between the former and the latter two were analyzed.Results SSDEweight(chest r=0.974,abdomen r=0.972)and SSDEBMI(chest r=0.933,abdomen r=0.950)were both highly correlated with SSDEstandard(all P＜0.01)and had good consistency.The root mean square error between SSDEweight and SSDEstandard of chest and abdominal CT was 0.245 and 0.249,between SSDEBMI and SSDEstandard was 0.653 and 0.956,respectively.Conclusion Body mass and BMI could be used to conveniently calculate SSDE value of chest and abdominal CT scanning in children,and the results had good consistency with that based on software.

Ultrasound-mediated sonodynamic therapy,chemodynamic therapy,immunotherapy and gene editing synergize the precise control of ultrasound with targeted properties of nanomaterials,hence promising for overcome the limitations of traditional cancer treatments.The advancements in ultrasound-mediated nanotherapy of tumors were reviewed in this article.

Prostate cancer is a common malignant tumor in males.Androgen deprivation treatment(ADT)is the main therapeutic method for prostate cancer,which often leads to changes of body composition(BC)characterized by sarcopenia,centripetal fat redistribution and osteoporosis.Imaging techniques can accurately and conveniently assess changes of BC.The research progresses of imaging evaluation on BC changes in prostate cancer patients after ADT were reviewed in this article.

Objective To compare the efficacy and safety of CT-guided percutaneous radiofrequency ablation(RFA)and cryoablation(CRYO)combined with synchronous biopsy of pulmonary nodules.Methods Totally 62 patients with pulmonary nodules who underwent CT-guided percutaneous ablation with either RFA(n=30)or argon-helium CRYO(n=32)combined with simultaneous biopsy were enrolled,and the regarding postoperative complication rates and 1-year local control outcomes were compared.Results All patients successfully completed both ablation and biopsy procedures.In RFA group,the mean diameter of lesion was(1.43±0.33)cm,and the biopsy positive rate was 90.00%(27/30).Post-biopsy intrapulmonary hemorrhage extent immediately increased by 0.60(0.28,1.63)cm.Hemoptysis,pneumothorax requiring chest tube placement and infectious cavities observed in 2(2/30,6.67%),6(6/30,20.00%)and 4 cases(4/30,13.33%),respectively,and the 1-year local control rate in RFA group was 90.00%(27/30).In CRYO group,the mean diameter of lesion was(1.59±0.34)cm,and the biopsy positive rate was 100%(32/32).Post-biopsy intrapulmonary hemorrhage extent increased by 1.20(0.60,1.83)cm.Hemoptysis occurred in 7 cases(7/32,21.88%),and pneumothorax requiring chest tube placement was noticed in 8 cases(8/32,25.00%),while no infectious cavity was observed.The 1-year local control rate in CRYO group reached 96.88%(31/32).Statistical difference of infectious cavity was found between groups(P＜0.05).Conclusion Simultaneous biopsy during CT-guided percutaneous RFA and CRYO for lung nodules were both efficient and safe,while the former with relative higher incidence of infectious cavity.

Objective To explore the efficacy and safety of TACE and apatinib combined with camrelizumab for treating giant hepatocellular carcinoma(HCC).Methods Totally 78 patients with giant HCC were retrospectively collected,including 22 cases received TACE and apatinib combined with camrelizumab(TACE+AC group)and 56 cases received TACE and apatinib(TACE+A group).Propensity score matching analysis was used to select 44 cases(TACE+A'group)from TACE+A group who were matched to those in TACE+AC group at 1:2 ratio.The overall survival(OS),progression-free survival(PFS)and the adverse events were recorded and compared among groups.Results Patients in TACE+AC group had a median OS of 17.8(95％CI:17.5-18.1)months and a median PFS of 8.8(95％CI:5.4-12.3)months,which in TACE+A'group was 9.8(95％CI:7.6-12.1)months and 5.5(95％CI:2.7-8.3)months,respectively.The overall OS rate and PFS rate in TACE+AC group were significantly higher than those in TACE+A' group(both P<0.05).The incidences of thyroid dysfunction,immune pneumonia and reactive cutaneous capillary endothelial proliferation in TACE+AC group were significantly higher than those in TACE+A' group(all P<0.05).No death associated with adverse events occurred.Conclusion Compared with TACE and apatinib,further combining with camrelizumab could get better survival benefit for giant HCC patients with acceptable adverse events.

Objective To observe the value of intratumoral tertiary lymphoid structure(TLS)for predicting prognosis of soft tissue sarcomas(STS)after cryoablation combined with immunotherapy.Methods Forty-three STS patients who underwent cryoablation were retrospectively enrolled,including 38 cases underwent cryoablation combined with but 5 cases without immunotherapy,among them 6 cases with but 37 cases without intratumoral TLS.The progression free survival(PFS)were compared between those with and without immunotherapy,as well as those with and without intratumoral TLS.The value of intratumoral TLS for predicting prognosis of STS after cryoablation combined with immunotherapy was analyzed with Cox regression and receiver operating characteristic curves.Results No significant difference of PFS was found between STS patients undwerwent cryoablation combined with and without immunotherapy(P＜0.05).Among 38 cases underwent cryoablation combined with immunotherapy,6 cases were found with but 32 cases without intratumoral TLS,and the median PFS of the former was longer than that of the latter(6 months vs.3 months,P＜0.05).Univariate and multivariate Cox regression analysis revealed that intratumoral TLS and interleukin 2 receptor(IL-R2)were both independent influencing factors of PFS of STS patients after cryoablation combined with immunotherapy(both P＜0.05).The area under the curve(AUC)of intratumoral TLS for predicting PFS of STS patients at 3,6 and 9 months was 0.550,0.577 and 0.699,of IL-R2 was 0.658,0.742 and 0.583,respectively,while of combination of the above two was 0.762,0.787 and 0.881,respectively,all higher than of each intratumoral TLS and IL-R2 alone(all P＜0.05).Conclusion Intratumoral TLS could be used to predict prognosis of STS after cryoablation combined with immunotherapy.Combining with IL-R2 might further improve its predictive efficacy.

Objective To observe the value of machine learning(ML)models based on quantitative ultrasound(QUS)and clinical indexes for predicting metabolic associated fatty liver disease(MAFLD).Methods Totally 298 patients underwent abdominal MR and QUS examinations were retrospectively enrolled,including 150 cases with and 148 cases without MAFLD.The patients were divided into training set(including 107 cases of MAFLD and 101 cases of non-MAFLD)and test set(including 43 cases of MAFLD and 47 cases of non-MAFLD)at a ratio of 7∶3.Features were selected using least absolute shrinkage and selection operator(LASSO)regression and logistic regression(LR),based on which predictive models were constructed using 6 ML classifiers,including Gaussian naive Bayes(GNB),LR,random forest(RF),support vector machine(SVM),extreme gradient boosting(XGBoost)and K-nearest neighbor(KNN),respectively.Then the receiver operating characteristic curves were drawn,and the area under the curve(AUC)and the Brier score were calculated to evaluate the predictive efficacy of the models.Results The elevated age,glutamic-pyruvic transaminase(GPT),glutamic-oxaloacetic transaminase(GOT),uric acid(UA),low-density lipoprotein cholesterol(LDL-C),controlled attenuation parameter(CAP),ultrasound-derived fat fraction(UDFF)and shear wave velocity(SWV),as well as blurred liver contour were all independent indicators for higher likelihood of MAFLD(all P＜0.05).The AUC and Brier score of XGBoost model in training set was 0.991 and 0.006,in test set was 0.973 and 0.069,respectively,both higher than those of other models,and decision curve analysis(DCA)indicated that XGBoost model had high net benefit.Conclusion ML models based on QUS and clinical indexes,especially XGBoost model had high efficacy for predicting MAFLD.